We have recently identified farnesol, an intermediate in the mevalonate pat
hway, as a potent endogenous modulator and blocker of N-type calcium channe
ls (Roullet, J. B., R. L. Spaetgens, T. Burlingame, and G. W. Zamponi. 1999
. J. Biol Chem. 274:25439-25446). Here, we investigate the action of struct
urally related compounds on various types of voltage-dependent Ca2+ channel
s transiently expressed in human embryonic kidney cells. 1-Dodecanol, despi
te sharing the 12-carbon backbone and headgroup of farnesol, exhibited a si
gnificantly lower blocking affinity for N-type Ca2+ channels. Among several
additional 12-carbon compounds tested, dodecylamine (DDA) mediated the hig
hest affinity inhibition of N-type channels, indicating that the functional
headgroup is a critical determinant of blocking affinity. This inhibition
was concentration-dependent and relatively non-discriminatory among N-, L-,
P/Q-, and R-Ca2+ channel subtypes. However, whereas L-type channels exhibi
ted predominantly resting channel block, the non-L-type isoforms showed sub
stantial rapid open channel block manifested by a speeding of the apparent
time course of current decay and block of the inactivated state. Consistent
with these findings, we observed significant frequency-dependence of block
and dependence on external Ba2+ concentration for N-type, but not L-type,
channels. We also systematically investigated the drug structural requireme
nts for N-type channel inhibition. Blocking affinity varied with carbon cha
in length and showed a clear maximum at C12 and C13, with shorter and longe
r molecules producing progressively weaker peak current block. Overall, our
data indicate that aliphatic monoamines may constitute a novel class of po
tent inhibitors of voltage-dependent Ca2+ channels, with block being govern
ed by rigid structural requirements and channel-specific state dependencies
.